Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement

ACCC gives nod to Woolworths pets deal with asset sales in tow

Carrie LaFrenz
Carrie LaFrenzSenior reporter

The competition regulator has finally given a green light to Woolworths’ acquisition of PETstock, a year after it made a play for the pet sector, forcing the target to sell some stores to get the deal over the line.

The purchase price for Woolworths’ 55 per cent stake in Petspiration Group, which trades as PETstock, is now expected to be $438 million, reduced from $586 million. The adjusted enterprise value is about $1.46 billion, the grocery giant said on Thursday.

CEO of Woolworths Brad Banducci, pictured here with his dog Juno, pushed into the pet sector following the COVID puppy boom.  

The COVID-19 pet boom spurred Woolworths to invest in the $10 billion specialty pet sector last December.

The nod from the regulator comes as Australia’s merger regime comes under the microscope, with Treasury in November revealing reforms and changes that could mean companies need approval from the Federal Court for acquisitions, and introduction of a mandatory notification scheme instead of the present voluntary system.

Clearance for the deal was held up when two months into the ACCC’s investigation, the regulatory timeline blew out as the ACCC evaluated historic acquisitions made by PETstock that had not been on its radar.

Advertisement

The Australian Competition and Consumer Commission said on Thursday that it will not oppose Woolworths’ acquisition and has accepted a court-enforceable undertaking from Woolworths to support PETstock’s divestitures.

ACCC chairwoman Gina Cass-Gottlieb said that while the asset sales resolve the regulator’s concerns in this transaction, dealing with competition issues in a historical way is not efficient or effective in keeping competition intact.

“The ACCC needs better laws to enable it to become aware of and properly scrutinise mergers before they occur, and to prevent those likely to substantially lessen competition,” she said.

“Consumers ultimately bear the risk that anti-competitive mergers will complete without scrutiny and increase prices, reduce quality or reduce service levels.”

Strong returns forecast

Woolworths’ investment in PETstock will be overseen by a combined board including the founding Young family, led by new chairman Colin Storrie. Mr Storrie just stepped down from Endeavour Group’s board, the liquor retailer in which Woolworths has a minority stake.

Advertisement

PETstock continued to grow over the past year with underlying sales increasing by 10 per cent to $892 million in the 12 months to October and underlying EBITDA relatively stable at $125 million, Woolworths said. The acquisition is tipped to close early in January.

“As we said at the time of the original announcement, this investment will enable Woolworths Group to meet more of our customers’ pet needs and is expected to deliver strong returns for shareholders,” Woolworths boss Brad Banducci said.

PETstock is the second-biggest player in the sector behind TPG Capital’s Greencross.

PETstock will sell 41 specialty pet retail stores, 25 co-located veterinary hospitals, four brands and two online retail stores to address the ACCC’s concerns.

Ms Cass-Gottlieb said the regulator had significant concerns that PETstock’s acquisitions of the Best Friends Pets, Pet City, and Animal Tuckerbox chains and the Pet & Aquarium Warehouse store in Eltham, Victoria may have contravened the Competition and Consumer Act.

She added PETstock’s decision to make numerous acquisitions of this scale without notifying the ACCC demonstrates the limitations of Australia’s current merger regime.

Advertisement

“The ACCC is particularly concerned that there may be anti-competitive acquisitions taking place without our knowledge under our current voluntary regime,” Ms Cass-Gottlieb said.

The next big deal that will fall to the ACCC to scrutinise will be the merger of drug wholesaler Sigma Healthcare by discount chain Chemist Warehouse which, if consummated, will create an $8.8 billion listed giant.

Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com

Read More

Latest In Retail

Fetching latest articles

Most Viewed In Companies